KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

CUSIP: 48576UAA4

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Debt / NOTE 3.000%10/1
Market price (% of par)
77.82%
Total 13F principal
$23,363,000
Principal change
$0
Total reported market value
$18,181,290
Number of holders
5
Value change
-$20,439
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 48576UAA4?
CUSIP 48576UAA4 identifies 48576UAA4 - KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 as of Q4 2024

As of 31 Dec 2024, KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1 was held by 5 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $23,363,000 in principal (par value) of the bond. The largest 5 bondholders included Affinity Asset Advisors, LLC, Opaleye Management Inc., Exome Asset Management LLC, BLB&B Advisors, LLC, and JPMORGAN CHASE & CO. This page lists 5 institutional bondholders reporting positions for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.